Medicinal Cannabis for Mental Health: What Does the Evidence Actually Show?

A sweeping new study is calling into question the use of medicinal cannabis for mental health. Doctors in the United States, United Kingdom and Australia frequently prescribe it for anxiety, depression and PTSD. But the latest research suggests the science has not caught up with the prescriptions, and in some cases, patients may be placed at greater risk.

A major review in The Lancet Psychiatry found little convincing evidence that medicinal cannabis helps treat mental health or substance-use disorders. Those using it faced roughly 75% higher odds of adverse side effects compared to those who did not.

What the Research Found on Cannabis and Mental Health Treatment

Researchers at the University of Sydney examined 54 randomised controlled trials from 1980 to 2025, covering 2,477 participants. Most were male (69%) and the average age was 33. It is one of the most thorough reviews of its kind.

The findings were stark. Cannabinoids, the active substances in cannabis, showed no significant benefit for anxiety disorders, psychotic disorders, PTSD, opioid use disorder or anorexia nervosa. The researchers concluded that cannabis-based treatments are “rarely justified” for routine clinical use in mental health settings.

Lead author Dr Jack Wilson was direct: “The routine use of medicinal cannabis could be doing more harm than good.” He warned of a greater risk of psychotic symptoms, cannabis use disorder, and delays to more effective care.

A few areas showed limited promise. These included insomnia, Tourette’s symptoms and certain autistic traits. But researchers flagged this evidence as low quality.

Why Medicinal Cannabis for Mental Health Is Under Scrutiny

Medicinal cannabis use has grown substantially across the English-speaking world. Depression, anxiety and PTSD are among the leading conditions cited in prescriptions. Yet the study found no randomised trials for depression met the review criteria. Data on ADHD, bipolar disorder and OCD was also insufficient to draw conclusions.

Dr Thea Gallagher, clinical associate professor of psychiatry at NYU Grossman School of Medicine, noted that earlier research often relied on smaller samples or self-reported symptoms. Neither can establish causation.

“This new review is the most comprehensive attempt to date to evaluate cannabis specifically for anxiety, depression and PTSD,” she said. She stressed that cannabis does have legitimate medical uses. Mental health conditions, however, are “not necessarily among them at this time.”

The researchers drew a clear distinction. Medicinal cannabis has demonstrated benefits for epileptic seizures, multiple sclerosis symptoms and certain chronic pain conditions. The concern is specifically about its growing use as a first-line treatment for mental ill-health.

The Risk of Delaying Proven Treatment

One of the more sobering findings is what reaching for cannabis first might mean for people who need real support.

Dr Jessica Watrous, clinical psychologist and chief clinical officer at Modern Health in California, acknowledged the wider reality. Mental health care can be expensive and hard to access. It is not surprising that people look for more immediate options.

But she raised a critical concern. “By using a more immediately available, but less evidence-backed intervention, it may delay getting support that does have strong evidence of effectiveness.”

That delay carries real consequences. People living with anxiety, depression or trauma deserve access to treatments that work. Using cannabis as a shortcut, when the science does not support it, risks prolonging suffering.

Red Flags to Watch For

Dr Gallagher offered practical guidance for those currently using cannabis. Changes in mood, motivation, sleep, concentration and social engagement are worth monitoring.

Warning signs include needing higher doses over time. Using cannabis to cope with stress is another red flag. So are increased paranoia or persistent mental fogginess. She advised taking periodic breaks to assess whether cannabis is helping or masking deeper issues.

Anyone whose functioning begins to decline should seek professional support. People with a personal or family history of psychosis face particular risk. Research links cannabis use to a measurably higher chance of psychotic symptoms in this group.

Study Limitations

The researchers acknowledged several limitations. Nearly half of the included studies (44%) were rated as high risk for bias. Flaws in design or reporting may affect the reliability of those findings.

The trials also varied considerably in product type, dosage, duration and patient demographics. That makes direct comparisons difficult.

Dr Gallagher noted that trial conditions rarely reflect real-world use. People often consume higher doses, use cannabis more frequently, and sometimes combine it with alcohol or other substances. Those factors could amplify risks significantly.

The Bottom Line

This study does not argue that cannabis has no place in medicine. What it challenges is routine use as a treatment for mental health conditions. For anxiety, depression and PTSD, the evidence is simply not there.

If someone is using cannabis to manage mental health symptoms, an honest conversation with a healthcare professional is a sensible next step. There may be a more effective, evidence-based path available.

Proven support through therapy, structured mental health programmes, medication or community resources remains the most reliable route to long-term recovery.

Source: foxnews